Keywords: barr, pliva, unit, approval, generic, pravastatin, pharmaceuticals

Barr's Pliva unit approval for generic pravastatin

Article | 04 December 2006

Barr Pharmaceuticals says that its recently-acquired Croatian subsidiary Pliva (Marketletters passim) has received final approval from the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in